Simponi 50MG/0.5ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FATXP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,999
Award facts
- Contract value 100% obligated
- $83,999.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83,999.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of SIMPONI 50MG/0.5ML. The contract was performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. This delivery order was awarded on a non-set-aside, competitive basis and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle and maintains a significant role as a pharmaceutical prime vendor for military healthcare systems.
SIMPONI is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions commonly required in military medical treatment facilities and veterans' healthcare programs. This transaction exemplifies the Defense Logistics Agency's ongoing pharmaceutical procurement strategy, which leverages established IDCs with major distributors to efficiently supply essential specialty medications and biologics to support military personnel and beneficiary healthcare needs. AmerisourceBergen's position as a critical federal pharmaceutical vendor reflects its demonstrated capability to meet federal procurement requirements across diverse therapeutic domains through competitive contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26FATXP?
SPE2DR26FATXP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FATXP worth?
The government has obligated $83,999 on SPE2DR26FATXP.
Is contract SPE2DR26FATXP an order under another contract?
Yes. SPE2DR26FATXP is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATXP competed?
The extent of competition for SPE2DR26FATXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award